Trial Profile
Phase II study of S-1 chemotherapy in elderly patients with advanced non-small cell lung cancer harboring no EGFR gene mutation.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 May 2011
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Feb 2011 New trial record